MedTrace Logo

Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)

NCT06220617 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3600

Last updated 2024-01-30

No results posted yet for this study

Summary

The primary objective of the study is to screen multi-omics markers in blood samples and construct a prediction model for CRC based on liquid biopsy, and we will further optimize the prediction model by validating its clinical performance externally.

Conditions

Sponsors & Collaborators

  • New Horizon Health Technology Co., Ltd

    collaborator UNKNOWN

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Kefeng Ding, MD · Second Affiliated Hospital, School of Medicine, Zhejiang University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-11
Primary Completion
2026-12-31
Completion
2027-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06220617 on ClinicalTrials.gov